We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
-1.25%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$16.9B
AUM Growth
-$410M
(-2.4%)
Cap. Flow
-$25.6M
Cap. Flow
% of AUM
-0.15%
Top 10 Holdings %
Top 10 Hldgs %
24.81%
Holding
859
New
90
Increased
491
Reduced
223
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TAHO
Tahoe Resources Inc
TAHO
|
+$203M |
| 2 |
Pan American Silver
PAAS
|
+$64.6M |
| 3 |
CIVI
Civitas Resources
CIVI
|
+$63M |
| 4 |
GPOR
Gulfport Energy Corp.
GPOR
|
+$58.6M |
| 5 |
ITC
ITC HOLDINGS CORP
ITC
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRO
Marathon Oil Corporation
MRO
|
+$108M |
| 2 |
SLB Ltd
SLB
|
+$65.3M |
| 3 |
Gilead Sciences
GILD
|
+$50M |
| 4 |
Core Laboratories
CLB
|
+$49.9M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$47.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 41.11% |
| 2 | Energy | 24.53% |
| 3 | Healthcare | 8.07% |
| 4 | Technology | 3.76% |
| 5 | Industrials | 3.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Sanofi
SNY
$103B
| $19M | 0.11% |
383,115
+35,175
| +10% | +$1.78M |
|
152
GSK
GSK
$104B
| $18.8M | 0.11% |
360,818
+74,536
| +26% | +$4.2M |
|
153
NXP Semiconductors
NXPI
$57.8B
| $18.8M | 0.11% |
190,991
-533
| -0.3% | -$54.7K |
|
154
Broadcom
AVGO
$1.85T
| $18.7M | 0.11% |
1,408,030
-97,100
| -6% | -$1.27M |
|
|
NVO
155
Novo Nordisk
NVO
$208B
| $18.3M | 0.11% |
669,306
-40,488
| -6% | -$1.14M |
|
156
Walmart Inc
WMT
$885B
| $18.3M | 0.11% |
773,802
-399,414
| -34% | -$10.2M |
|
157
Patterson-UTI
PTEN
$3.98B
| $18.2M | 0.11% |
967,552
-75,159
| -7% | -$1.56M |
|
158
Home Depot
HD
$331B
| $18M | 0.11% |
162,113
-86,357
| -35% | -$9.67M |
|
159
Eli Lilly
LLY
$1.02T
| $17.8M | 0.11% |
213,400
-4,327
| -2% | -$330K |
|
160
Bristol-Myers Squibb
BMY
$133B
| $17.7M | 0.1% |
266,056
+42,033
| +19% | +$2.77M |
|
161
Abbott
ABT
$183B
| $17.7M | 0.1% |
359,632
+42,225
| +13% | +$2.03M |
|
|
QGENF
162
DELISTED
QIAGEN NV
QGENF
| $17.4M | 0.1% |
703,922
+19,565
| +3% | +$485K |
|
163
Ionis Pharmaceuticals
IONS
$8.6B
| $17.1M | 0.1% |
297,615
+54,250
| +22% | +$3.45M |
|
|
SHPG
164
DELISTED
Shire pic
SHPG
| $17.1M | 0.1% |
70,625
+14,979
| +27% | +$3.71M |
|
165
Teva Pharmaceuticals
TEVA
$40.8B
| $17M | 0.1% |
287,577
+57,685
| +25% | +$3.56M |
|
166
Bausch Health
BHC
$2.58B
| $16.9M | 0.1% |
76,219
+353
| +0.5% | +$78.3K |
|
167
AstraZeneca
AZN
$263B
| $16.7M | 0.1% |
262,648
+34,592
| +15% | +$2.37M |
|
168
Micron Technology
MU
$930B
| $16.7M | 0.1% |
887,221
+137,906
| +18% | +$3.68M |
|
|
RCPT
169
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $16.7M | 0.1% |
+87,755
| New | +$14.5M |
|
|
RDC
170
DELISTED
Rowan Companies Plc
RDC
| $16.4M | 0.1% |
775,283
-85,180
| -10% | -$1.8M |
|
171
Perrigo
PRGO
$1.4B
| $16.2M | 0.1% |
87,672
+15,007
| +21% | +$2.86M |
|
172
Alkermes
ALKS
$8.22B
| $16.1M | 0.1% |
250,513
+22,002
| +10% | +$1.35M |
|
173
Analog Devices
ADI
$179B
| $16M | 0.09% |
249,343
-18,097
| -7% | -$1.17M |
|
|
ALO
174
DELISTED
Alio Gold Inc
ALO
| $16M | 0.09% |
2,860,357
+681,787
| +31% | +$4.3M |
|
175
Idexx Laboratories
IDXX
$44.1B
| $15.7M | 0.09% |
245,079
+21,155
| +9% | +$1.46M |
|
Similar funds
VanEck Associates's Q2 2015 Portfolio in Review
As of Q2 2015, VanEck Associates held 859 positions worth $16.9B, down 2.4% from $17.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
VanEck Associates's Q2 2015 filing shows 90 new, 491 increased, 223 reduced and 46 closed positions. Its largest new stake was ITC HOLDINGS CORP: 1,307,283 shares worth $42.1M. The largest sale was Marathon Oil Corporation, an estimated $108M.
By sector, the portfolio is most concentrated in Materials at 41% of assets, down from 42% a quarter earlier, followed by Energy and Healthcare.
- VanEck Associates's largest Q2 2015 buy was ITC HOLDINGS CORP: 1,307,283 shares worth $42.1M.
- VanEck Associates added most to Tahoe Resources Inc in Q2 2015, an estimated $203M increase.
- VanEck Associates's biggest Q2 2015 reduction was Marathon Oil Corporation, cutting an estimated $108M.
- VanEck Associates fully exited Express Scripts Holding Company in Q2 2015, selling an estimated $47.8M.
- VanEck Associates's ten largest holdings make up 25% of its $16.9B portfolio in Q2 2015.
- VanEck Associates opened 90 new positions and closed 46 in Q2 2015.
- VanEck Associates's portfolio value fell 2.4% quarter-over-quarter to $16.9B.
Based on VanEck Associates's 13F filing for Q2 2015, filed 12 Aug 2015.